Subscribe free

Sarcoma & rare tumors ·

Endoscopic resection proves safe for early-stage duodenal tumors

In a comprehensive review of 40 patients with grade 1-2 duodenal neuroendocrine tumors, endoscopic resection emerged as a viable first-line treatment option. Notably, ligation-assisted endoscopic mucosal resection achieved a remarkable 100% complete resection rate, with only one case of perforation successfully managed endoscopically. During a mean follow-up of nearly five years, no patients experienced metastasis or tumor recurrence, highlighting the procedure’s potential in avoiding unnecessary surgical interventions in selected cases.

Journal Article by Lee CM, Choi CW (…) Hwang SH et 7 al. in Scand J Gastroenterol

read the whole article in Scand J Gastroenterol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Sarcoma & rare tumors.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Sarcoma & rare tumors

The latest stitches

Ann Surg Oncol26 Oct 2026

SSTR PET finds more distant disease in GEP-NETs

In this 24-year surgical cohort, SSTR PET identified bone and retroperitoneal nodal metastases more often than Octreoscan—findings that may matter for operative planning.

Ann Surg Oncol11 May 2026

Mapping Surgical Evidence for GEP-NETs

Surgical management of gastro-entero-pancreatic neuroendocrine tumors is inconsistent, highlighting the need for clearer guidelines.

All papers in Sarcoma & rare tumors →